loader from loading.io

In the News.. CGM Disqualifies High School Swimmer, Dexcom Smoothing, T2 Remission and more!

Diabetes Connections | Type 1 Diabetes

Release Date: 09/03/2021

In the News.. T1D increasing in older adults, new iCGM designation, low BG prevention tested, and more! show art In the News.. T1D increasing in older adults, new iCGM designation, low BG prevention tested, and more!

Diabetes Connections | Type 1 Diabetes

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: more older adults are being diagnosed with type 1 and people with T1D are living longer, Eversense gets iCGM designation, new drug to prevent low BG is being tested, Tandem diabetes app recall, and more! Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Here's where to...

info_outline
"You are raising fearless children" journalist Madison Carter speaks at Moms' Night Out Charlotte

Diabetes Connections | Type 1 Diabetes

This week, what growing up with diabetes meant for career choices, financial decisions, and family relationships. Madison Carter is a local news anchor who makes T1D very visible – and she does not hold back. She’s generous with incredible insight into how she was raised, sacrifices her family made and what her mom and dad have to say now. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from...

info_outline
“As active as I want to be” - Dianne Mattiace uses Eversense CGM to thrive with T1D in her 70s show art “As active as I want to be” - Dianne Mattiace uses Eversense CGM to thrive with T1D in her 70s

Diabetes Connections | Type 1 Diabetes

This week, managing type 1 diabetes into your 70s is a bit of uncharted waters.. While thankfully more and more people are living long with T1D, that wasn’t always the case. I’m taking to Dianne Mattiace who is in her early 70s and was diagnosed as an adult, 30 years ago. She was the first person in the US to use the Eversense CGM when it was approved in 2018 and she’s still using it today. She answers your questions about this implantable CGM, why she’s stayed with it and what else she does to manage in retirement and beyond.   This podcast is not intended as medical advice. If...

info_outline
In the News...  Ingredients linked to T2D, genetic T1D research, new SGLT-2 guidelines and more! show art In the News... Ingredients linked to T2D, genetic T1D research, new SGLT-2 guidelines and more!

Diabetes Connections | Type 1 Diabetes

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study links emulsifiers, a common ingrediant, to type 2 diabetes, reserachers map out the pancreas in a new way that's already yielding new information, new guidliens about using GLP-1s and SGLT-2 medications with exisiting oral meds, genetic T1D studies and more!  Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and...

info_outline
“How can we continue to move T1D to the background?” Medtronic’s Dr. Jennifer McVean show art “How can we continue to move T1D to the background?” Medtronic’s Dr. Jennifer McVean

Diabetes Connections | Type 1 Diabetes

This week, catching up with Medtronic’s Senior Director of Global Medical Affairs Dr. Jennifer McVean. It’s been one year since the 780G was approved in the US, what does the device – and its seven-day infusion set – look like in the real world. Plus, we have a big discussion about the future of type 1 diabetes – Dr. McVean has lead some significant trials – she lives with type 1 and has some big ideas about changes she’d like to see. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.   Find out...

info_outline
Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin show art Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin

Diabetes Connections | Type 1 Diabetes

This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that twists off – with very different software – Tidepool Loop. The company behind this pump – they’re called Sequel - wants to be different as well, hoping to offer solutions to bigger issue than basal and bolus rates. It’s very ambitious and we have a wide ranging conversation about it all with Sequel’s CEO Alan Lotvin This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Our...

info_outline
In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more! show art In the News... Dexcom-to-watch update, Wegovy studies, night time hypo research and more!

Diabetes Connections | Type 1 Diabetes

It’s In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: Dexcom launches direct-to-watch with the G7 in the UK and Ireland, more studies looking at heart benefits with Wegovy and diabetes, a new T1D study investigating an injectable to prevent overnight hypoglycemia, lobbying for Levimir, a ChatGPT diabetes diagnosis and more! Find out more about Please visit our Sponsors & Partners - they help make the show possible! Learn more about from extreme temperatures Learn more about Drive The best way to keep up with Stacey and the show...

info_outline
The FDA took down this teen’s free bolus calculator. He needs your help to bring it back. show art The FDA took down this teen’s free bolus calculator. He needs your help to bring it back.

Diabetes Connections | Type 1 Diabetes

There used to be a lot of bolus calculators in the app store, maybe you’ve used one and haven’t updated it in a while. Don’t try now.. it’s likely been pulled. Apple and the FDA are cracking down on this types of tools – no unreasonable, right? But surely there are more coming.. how hard can it be to create a simple insulin bolus calculator that’s FDA approved, easy to find, easy to use, free, and doesn’t require you buy anything else? Turns out, it’s pretty darn hard. We’re talking about that today with the inventor of such an app with an interesting story – he’s still...

info_outline
Diabetes Technology: Expectation vs Reality with Dr. Stephen Ponder show art Diabetes Technology: Expectation vs Reality with Dr. Stephen Ponder

Diabetes Connections | Type 1 Diabetes

Diabetes technology is getting better and better. We have automated insulin systems that link pumps and CGMs, and smart insulin pens that have precise calculations and reminders. It’s been quite the evolution over the past few years! But outcomes – time in range, A1Cs, aren’t exactly where experts thought they might be. I’m talking to Dr. Stephen Ponder about why that is, how a social media post he shared about this caused a strong reaction, and what does work for better long term outcomes. This podcast is not intended as medical advice. If you have those kinds of questions, please...

info_outline
In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more! show art In the News... diabetes drug pricing, vial shortage, pump using Tidepool Loop cleared, insulin cows and more!

Diabetes Connections | Type 1 Diabetes

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: a new study shows that drugs like Ozempic can be produced for just a few dollars, we upate the insulin vial shortage Lilly announced, a new pump has been FDA cleared, a genetically modified cow can product human insulin, and more! Transcript and links below Find out more about  Please visit our Sponsors & Partners - they help make the show possible! Learn more about   from extreme temperatures Learn more about  Drive  The best way to keep up...

info_outline
 
More Episodes

This week "In the News.." Did wearing a CGM in the water disqualify a high school swimmer? What his family says happened and why they're suing. The ADA wants to start using the word "remission" instead of "reversed" for type 2 diabetes - we'll talk about why. Dexcom says they are no long smoothing data, new migraine and diabetes research and T1Interntioanl is out with their latest survey results about the price and use of insulin.

Join us Live on Facebook each Wednesday at 4:30pm EDT!

Check out Stacey's book: The World's Worst Diabetes Mom!

Join the Diabetes Connections Facebook Group!

Sign up for our newsletter here

-----

Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
-----

Get the App and listen to Diabetes Connections wherever you go!

Click here for iPhone      Click here for Android

Episode transcript below

 

Hello and welcome to Diabetes Connections In the News! I’m Stacey Simms and these are the top diabetes stories and headlines of the past seven days.  As always, I’m going to link up my sources in the Facebook comments - where we are live - and in the show notes at d-c dot com when this airs as a podcast.. so you can read more if you want, whenever you want.

XX

In the News is brought to you by Real Good Foods! Find them in your local grocery store, Target or Costco. Real Food You Feel Good About Eating.

XX

Top story this week.. A discrimination complaint against the Colorado High School Activities Association has been filed with the U.S. Department of Justice. At issue? A student was disqualified for wearing his continuous glucose monitor.  Ethan Orr is a 16-year-old swimmer whose team qualified for the state championships.

According to his attorney Orr wore a blood glucose monitor taped to his arm during seven prior matches, including the one in which his team qualified for the state championships, with no issue.

But at this meet, the ref said Orr would not be allowed to swim in his last race because of his glucose monitor and tape. They didn’t have a sub so the whole team was disqualified.

The attorney says, “This is simply blatant discrimination against a kid with a disability, and it led to unnecessary and unfair consequences to him, his teammates, and the school,”

According to the lawsuit, Orr is protected under two federal laws - the Americans with Disabilities Act and Section 504 of the Rehabilitation Act of 1973.

I’ve reached out to the local reporter on this story and hope to talk to the family soon

XX

People with type 2 diabetes should be considered in remission after sustaining normal blood glucose levels for three months or more without medication. That’s a new consensus statement from the American Diabetes Association® and several other international groups.

They recommend testing every year to determine long term maintenance.

The real news here - as I see it - is trying to get people to stop saying “Reversal” or “cure” when it comes to diabetes. The statement here doesn’t seem to be about the science, but says the word remission “strikes an appropriate balance” between the diabetes not being active and progressive, but also recognizing improvement may not be permanent.

https://www.diabetes.org/newsroom/press-releases/2021/international-experts-outline-diabetes-remission-diagnosis-criteria

XX

Got lots of comments and questions about some changes noticed on the Dexcom G6 app recently. Turns out, Dexcom has removed what’s called data smoothing from its most recent update. As of August 9th they say

“The Dexcom G6 app used to smooth all but your current reading on your trend graph. With data smoothing, there can be some differences between the G6 reading you see in real time (the white circle) and the G6 readings you see in the past on your graph (black dots). I’m showing a photo here - I’ll post this with the podcast episode for those listening.

 

To avoid these differences, we removed data smoothing from the Dexcom G6 app in the 1.9 release, but the Follow app and Receiver continue to smooth past CGM data. We will remove smoothing in an upcoming Follow app release to match the G6 app, but we don’t plan to remove data smoothing from the Receiver.”

 

These differences don’t affect the real-time glucose data, alarm, or alerts. Honestly, I’m not sure why they’re doing this or why they smoothed in the first place.. but we’ll follow up and try to find out more

XX

Not a lot of answers here, but this is interesting.. apparently, people with type 2 diabetes are unlikely to develop migraines and people who get regular migraines are less likely to develop diabetes. To find out why.. scientists are looking at two small proteins that are linked to migraine and drive production of insulin.

This team from the University of Tennessee says some of the newer treatments for migraines could increase the risk of diabetes because of the use of these proteins. They want to figure out how to prevent that.

 

https://www.fiercebiotech.com/research/mouse-study-shows-how-causes-behind-migraine-pain-can-improve-diabetes-treatment

XX

T1International is out with results of their 2020 global out of pocket cost survey for people with type 1 diabetes.

Worldwide, one out of every four respondents reported having under-used their insulin at least once within the last year due to high cost.

63.2% of participants reported disruption of insulin supplies and 25.3% reported an increase of insulin prices related to the COVID-19 pandemic.

They’ve conducted this survey every two years since 2016, adding additional questions each year. This time, the Results were published as a research paper in the Journal of Diabetes Research and Clinical Practice, linked in the show notes.

https://www.t1international.com/access-survey/

XX

More to come, including news about a rare form of diabetes, but first, I want to tell you about one of our great sponsors who helps make Diabetes Connections possible.

Real Good Foods. Where the mission is Be Real Good

They make nutritious foods - grain free, high in protein, never added sugar and from real ingredients - I was in Target this week and I saw the new Entrée bowls, I bought the Lemon Chicken and the Lasagna. The Lemon chicken was great! It uses hearts of palm pasta instead of regular noodles which I thought sounded odd but really tasted good. They keep adding to the menu line! You can buy online or find a store near you with their locator right on the website. I’ll put a link in the FB comments and as always at d-c dot com.

Back to the news..

XX

This is from the UK but I think it’s an important reminder that there are more than 2 types of diabetes. It’s new plan to discover and treat mono-genetic diabetes. That’s caused by a single gene mutation - although the specific gene affected can differ. The condition occurs in two types, neonatal - which can occur within the first six months of life - and MODY that develops later, often before the age of 25. About 2% of all diabetes cases are thought to be monogenetic.. the National Health System in England is forming a new training and treatment program to make sure these patients received the correct treatment sooner.

https://www.theguardian.com/society/2021/aug/30/nhs-england-to-train-staff-in-all-trusts-to-spot-rare-type-of-diabetes

XX

And finally, thousands of people in the path of Hurricane Ida are still without power and possibly need help getting their medication. I want to make you aware of the Diabetes Disaster Response Coalition (DDRC).

This is a coalition of lots of diabetes groups - if you need immediate help or want to plan for an emergency, they have the resources.

Physicians and health care providers can call 1-314-INSULIN to report diabetes supply shortages and request support.  People with diabetes and their loved ones can call 1-800-DIABETES (800.342.2383) is available to support people with diabetes and their loved ones for more information.

https://diabetesdisasterresponse.org

XX

Please join me wherever you get podcasts for our next episode -Tuesday -  we’re talking to the folks from Walmart about their deal with Novo to sell their own brand of Novolog Insulin.. The episode out right now is with MannKind, makers of Afrezza inhalable insulin.

That’s In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.